Prime Contractor Head-to-Head Analysis
LEIDOS BIOMEDICAL RESEARCH INC vs. THE BOEING COMPANY
Comparative federal market share, recompete retention probability, agency obligations, and socioeconomic classifications.
Comparison Highlights
Verified SAM.gov & FPDS DataComparing federal prime contracting performance between LEIDOS BIOMEDICAL RESEARCH INC and THE BOEING COMPANY: LEIDOS BIOMEDICAL RESEARCH INC holds $16.71B in lifetime obligations with a 89.0% recompete retention rate, while THE BOEING COMPANY records $478.32B with a 89.6% retention rate.
•LEIDOS BIOMEDICAL RESEARCH INC Lifetime Spend: $16.71B
•THE BOEING COMPANY Lifetime Spend: $478.32B
•LEIDOS BIOMEDICAL RESEARCH INC Recompete Win %: 89.0%
•THE BOEING COMPANY Recompete Win %: 89.6%
•LEIDOS BIOMEDICAL RESEARCH INC Top Agency: Department of Health and Human Services
•THE BOEING COMPANY Top Agency: Department of Defense
Core Procurement Metrics Side-by-Side
Entity A
Full Profile →LEIDOS BIOMEDICAL RESEARCH INC
Total Lifetime Obligations:$16.71B
Trailing 12M Obligations:$5.85B
Recompete Win Rate:89.0%
Active Prime Task Orders:28
Average Award Cycle:50 Days
Primary Industry (NAICS):541512
Entity B
Full Profile →THE BOEING COMPANY
Total Lifetime Obligations:$478.32B
Trailing 12M Obligations:$167.41B
Recompete Win Rate:89.6%
Active Prime Task Orders:221
Average Award Cycle:54 Days
Primary Industry (NAICS):541512